Estrogen and thromboembolic disorders: should patients stop hormones prior to cosmetic surgery?
【연구 목적】 경구 피임약 및 호르몬 대체 요법(EST)이 혈전색전증 위험을 증가시킨다는 기존 지식을 바탕으로, 건강 상태가 양호한 미용 수술 환자에서 혈전색전증 발생 위험을 최소화하기 위한 전후 호르몬 중단 기간에 대한 임상적 권고를 제시한다.
APA
Shiffman MA (2003). Estrogen and thromboembolic disorders: should patients stop hormones prior to cosmetic surgery?. Journal of women's health (2002), 12(9), 853-5; discussion 855. https://doi.org/10.1089/154099903770948078
MLA
Shiffman MA. "Estrogen and thromboembolic disorders: should patients stop hormones prior to cosmetic surgery?." Journal of women's health (2002), vol. 12, no. 9, 2003, pp. 853-5; discussion 855.
PMID
14670164
Abstract
Oral contraceptives and replacement estrogenic hormones have been associated with a significant risk of thromboembolism. Cosmetic surgery consists of elective procedures in otherwise healthy individuals. The prospect of thromboembolism should be diminished in these patients by avoiding those factors that may give rise to the problem. Stopping oral contraceptives and replacement estrogens three weeks before surgery to two weeks after surgery is not difficult for most patients and should be part of the custom and practice of all cosmetic surgeons.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | Oral contraceptives
|
scispacy | 1 | ||
| 약물 | Oral contraceptives
|
C0009905
Contraceptives, Oral
|
scispacy | 1 | |
| 약물 | hormones
|
C0019932
Hormones
|
scispacy | 1 | |
| 약물 | estrogens
|
C0014939
estrogens
|
scispacy | 1 | |
| 질환 | thromboembolic
|
C0333214
thromboembolic
|
scispacy | 1 | |
| 질환 | thromboembolism
|
C0040038
Thromboembolism
|
scispacy | 1 | |
| 기타 | Estrogen
|
scispacy | 1 |
MeSH Terms
Contraceptives, Oral, Hormonal; Contraindications; Elective Surgical Procedures; Female; Hormone Replacement Therapy; Humans; Postmenopause; Postoperative Complications; Risk Factors; Surgery, Plastic; Thromboembolism; Women's Health